Mounjaro vs Wegovy vs Saxenda – Weight Loss Injection Comparison

Choosing weight loss injections can feel confusing. Headlines, ads, and mixed advice make it hard to see what truly differs from one option to another. A clear, side‑by‑side look can cut through the noise and help you ask the right questions at your next appointment. Here, we compare the three clinically approved options most people hear about: Mounjaro, Wegovy, and Saxenda.

We’ll outline how each works, who it may suit, dosing schedules, common side effects, expected outcomes, and practical considerations like access. This overview sets the stage for a balanced comparison so you can weigh benefits and trade‑offs without hype or generic tips.

Key Takeaways: What You Need to Know Before Choosing Your Weight Loss Injection

• Mounjaro, Wegovy, and Saxenda are all prescription-only weight loss injections with distinct mechanisms, dosing schedules, and effectiveness.
• Mounjaro offers the highest weight loss at around 20-21%, followed by Wegovy at 15%, and Saxenda at 8%.
• Mounjaro and Wegovy are weekly injections, while Saxenda requires daily doses, affecting convenience and long-term commitment.
• Common side effects for all include gastrointestinal issues like nausea and constipation, especially during dose increases.
• Treatment costs vary, with Mounjaro and Wegovy being more expensive, while Saxenda’s cost increases with higher doses.
• All three treatments require a prescription and medical consultation to ensure safe and appropriate use.

Overview of Mounjaro, Wegovy, and Saxenda

New to weight loss injections? Here’s a clear, side-by-side look at the three MHRA-approved options: Mounjaro (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide). These UK-approved treatments regulate appetite and enhance satiety, but they differ significantly in efficacy and administration.

Mounjaro has shown to be the most effective for weight loss, followed by Wegovy and then Saxenda. We’ll focus on how each works, how they’re taken, and what clinical trials have reported. Percentages below reflect average reductions in body weight alongside lifestyle support; individual results vary.

Maximise Your Weight Loss Potential with Proven Injections

• Clinically proven weight-loss treatments
• Support for healthy eating habits
• Expert meal-planning guidance

View All Treatments

• Mounjaro (tirzepatide)

MHRA status: Approved for weight management in eligible adults.

Mechanism: Dual GIP + GLP‑1 receptor agonist.

Administration: Once‑weekly subcutaneous injection with step‑up dosing.

Typical weight loss in trials: Around 15–21% average body weight reduction over ~72 weeks alongside lifestyle support.

• Wegovy (semaglutide)

MHRA status: Approved for weight management in eligible adults.

Mechanism: GLP‑1 receptor agonist.

Administration: Once‑weekly subcutaneous injection with gradual dose escalation.

Typical weight loss in trials: About 10–15% average reduction over ~68 weeks with lifestyle support.

• Saxenda (liraglutide)

MHRA status: Approved for weight management in eligible adults.

Mechanism: GLP‑1 receptor agonist.

Administration: Once‑daily subcutaneous injection with step‑wise titration.

Typical weight loss in trials: Approximately 5–8% average reduction over ~56 weeks with lifestyle support.

Key differences to note: Weight loss injection Mounjaro’s dual action (GIP + GLP‑1) vs. GLP‑1 alone for Wegovy and Saxenda; weekly injections for Mounjaro and Wegovy vs. daily for Saxenda; and higher average weight-loss percentages reported in trials for the weekly options compared with daily liraglutide.

Individual results and suitability vary, and medical guidance is essential. In short, Saxenda vs Wegovy in terms of mechanism, and Mounjaro vs Saxenda in terms of dosing frequency and weight loss effectiveness.

Safety and Side Effects Comparison

Below is a factual, evidence-based comparison of weight loss injection Mounjaro (tirzepatide), Wegovy (semaglutide), and Saxenda (liraglutide), focusing on common side effects, rare but serious adverse effects reported in studies, and key contraindications. This is intended to help readers understand the safety profiles of each weight loss injections.

Common Side Effects (Observed in Trials & Labels)

Mounjaro (tirzepatide)

• Nausea, vomiting, diarrhea, constipation, abdominal pain
• Decreased appetite
• Injection site reactions (less common)

Wegovy (semaglutide)

• Nausea, diarrhoea, vomiting, constipation
• Stomach (abdomen) pain, headache, fatigue
• Dizziness, bloating, gas, indigestion, low blood sugar (especially in type 2 diabetes)

Saxenda (liraglutide)

• Nausea, diarrhoea, constipation, vomiting
• Injection site reaction, low blood sugar (hypoglycemia)
• Headache, dizziness, tiredness

Rare but Serious Adverse Effects

Shared or Class-Level Risks (GLP-1 / GIP-GLP-1 drugs)

• Thyroid C-cell tumours: Boxed warnings for Mounjaro, Wegovy, and Saxenda weight loss injection due to thyroid C-cell tumours seen in rodent studies; relevance to humans is unknown but contraindications apply.
• Pancreatitis: Reported with GLP-1 receptor agonists; ongoing monitoring recommended.
• Gallbladder and kidney issues: Cases of gallbladder disease and kidney problems have been observed, particularly with GI fluid loss leading to dehydration (label warnings for Saxenda).

Cost and Accessibility Comparison

This section outlines practical information on costs, prescription requirements, and availability of weight loss injections (Mounjaro, Wegovy, Saxenda) in the UK, based primarily on prices listed on your clinic’s website.

Average Monthly Costs (UK Private Market)

Mounjaro (tirzepatide) – Private prescription

• Starting dose (2.5 mg): £189 per month (4 weekly weight loss injections).
• Mid-range doses (7.5–10 mg): £306–£330 per month.
• Higher maintenance doses (15 mg): £367 per month.
  Ranges reflect incremental dose increases over the first 20+ weeks of treatment.

Wegovy (semaglutide) – Private prescription

• Starter dose (0.25 mg): £139 per month (4 weekly weight loss injections).
• Mid titration doses (0.5–1.7 mg): £179–£237 per month.
• Maintenance dose (2.4 mg): £287 per month.

Saxenda (liraglutide) – Private prescription

• Weekly pricing varies with dose escalation. For 4 doses per week:
  • Week 1: £74.99
  • Week 2: £149.99
  • Week 3: £224.99
  • Week 4: £299.95
  • Week 5+ (maintenance): £374.95 per month of daily dosing.

Note: These prices (based on private prescriptions) include the cost of the medication plus the prescription service as listed on the clinic website. They reflect typical monthly supplies (4 weeks for Mounjaro/Wegovy, weekly escalation for Saxenda weight loss injection).

Choosing the Right Injection for You

For first-time users, choosing between Mounjaro, weight loss injection Wegovy, and Saxenda pen comes down to personal goals, tolerability, and practical considerations not a single “best” option.

Key factors to consider:

• Weight-loss goals: Each injection delivers different average results in studies. Be clear about what you’re aiming for and over what timeframe.
• Side effects: All commonly cause nausea and other digestive symptoms, especially during dose increases. Individual tolerance varies.
• Injection schedule: Weight loss shot Mounjaro and Wegovy for weight loss are typically weekly; Saxenda requires daily injections. Convenience matters for long-term use.
• Cost: These treatments are usually private in the UK, with ongoing monthly costs that increase as doses rise. Consider long-term affordability, not just starting prices.
• Medical suitability: Your health history and current medications are critical in determining which options are safe.

Always involve a healthcare professional

All three medications require a prescription and medical assessment. A qualified clinician should review your medical history, explain risks, and help determine suitability before you start.

Lifestyle support still matters

Best results are seen when weight loss injections are combined with:

• A balanced, calorie-controlled diet
• Regular physical activity
• Sustainable daily habits

These treatments support weight loss; they don’t replace lifestyle changes.

Consideration Before Starting

Mounjaro, Wegovy, and Saxenda differ in effectiveness, side-effect profiles, and dosing schedules. They also vary in cost and accessibility. However, all are prescription-only treatments designed to support weight loss when combined with long-term lifestyle changes. Choosing between them depends on clinical suitability, personal preferences, and realistic expectations.

Results and tolerability vary between individuals; all options require a medical assessment, and costs are ongoing in the UK private setting. Safe use starts with informed decision-making and professional guidance. If you’re exploring your options, clinics such as Mayfair Weight Loss Clinic offer structured medical consultations to assess eligibility and provide ongoing support helping ensure any treatment is approached responsibly, safely, and alongside diet and activity changes.

Frequently Asked Questions

Can I use Saxenda vs Wegovy or Mounjaro vs Saxenda together?

No. Mounjaro, Wegovy, and Saxenda should not be used at the same time. They work on similar pathways, and combining them increases the risk of side effects without proven benefit.

Are they available online?

Yes, but only with a valid prescription. UK users typically access them through online clinics or pharmacies after a medical assessment by a qualified prescriber.

How long before I see results?

Many people notice appetite changes or early weight loss within the first few weeks, with more visible results usually developing over 2–3 months as doses are gradually increased.

Are they safe for everyone?

No. They are not suitable for everyone. Certain medical conditions (such as specific thyroid disorders) and individual risk factors may rule them out, which is why a clinical review is required.

How often do I need to inject?

Weight loss shot Mounjaro and Wegovy for weight loss are typically taken once weekly, while Saxenda is taken daily. Weight loss injections are an important practical consideration.

What are the most common side effects?

All three commonly cause gastrointestinal symptoms such as nausea, vomiting, diarrhoea, constipation, and reduced appetite, especially during dose increases.

Do I still need diet and exercise?

Yes. These medications work best alongside a balanced diet, regular physical activity, and sustainable lifestyle habits.

What happens if I stop treatment?

Weight regain is possible after stopping. Long-term results usually depend on maintaining healthy habits, whether or not medication continues.